Insider · CIK 0001298079
Romulus K Brazzell
Files at KALA (KALA BIO, Inc.). First filing Jan 7, 2025, latest Oct 24, 2025.
Romulus K Brazzell files SEC Form 4 as officer at KALA (KALA BIO, Inc.). Since Jan 7, 2025, Romulus K Brazzell has reported 0 open-market buys worth $0 and 4 open-market sells worth $92k, the latest filed on Oct 24, 2025.
A track record needs three past buys with six months of prices behind them; Romulus K Brazzell has 0, so none is measured yet.
The newest scored trade: sold $39k of KALA on Oct 22, 2025, filed Oct 24, 2025, scored 56 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $39k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KALA: KALA BIO, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | KALA BIO, Inc. | $39k 46,748 shares | -57% | 0% from low-96% from high | |
| 10Weak | KALA BIO, Inc. | $21k 5,251 shares | -6% | +36% from low-64% from high | |
| 10Weak | KALA BIO, Inc. | $14k 3,687 shares | -4% | +39% from low-63% from high | |
| 10Weak | KALA BIO, Inc. | $19k 2,446 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 22, 2025 | KALA KALA BIO, Inc. | 46,748 0.67% of outstanding | $39k | Oct 22, 2025 | none |
| Jun 24, 2025 | KALA KALA BIO, INC. | 5,251 0.08% of outstanding | $21k | Jun 24, 2025 | $14k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock | -46,748 | $0.83 | $39k | 35,952 | Oct 24, 2025 |
| Jun 24, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -5,251 | $4.01 | $21k | 82,698 | Jun 26, 2025 |
| Jun 3, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -3,687 | $3.74 | $14k | 87,949 | Jun 4, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Common Stock | +10,100 | $0.00 | $0 | 94,864 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -2,446 | $7.63 | $19k | 92,418 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Stock Option (right to buy)derivative | +45,200 | $0.00 | $0 | 45,200 | Jan 7, 2025 |
Questions about Romulus K Brazzell
Answered from the filings on this page, as of the latest one.
Is Romulus K Brazzell buying or selling?
In the last 12 months Romulus K Brazzell reported 0 open-market buys worth $0 and 1 open-market sell worth $39k on SEC Form 4; the latest was sold $39k of KALA on Oct 22, 2025. Grants, option exercises and tax withholding are not counted.
How did Romulus K Brazzell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Romulus K Brazzell has 0.
Where does Romulus K Brazzell file Form 4?
Romulus K Brazzell has filed Form 4 at KALA (KALA BIO, Inc.) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.